- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2006
- Public Summary Document (PSD) July 2006 PBAC Meeting - PDF
Deferasirox – July 2006
Deferasirox, dispersible tablet, 125 mg, 250 mg and 500 mg, Exjade®, July 2006
Last updated
27 October 2006